Last reviewed · How we verify
cisatracurium besylate,propofol,remifentanil,sevoflurane
cisatracurium besylate,propofol,remifentanil,sevoflurane is a Small molecule drug developed by First Affiliated Hospital Xi'an Jiaotong University. It is currently FDA-approved.
At a glance
| Generic name | cisatracurium besylate,propofol,remifentanil,sevoflurane |
|---|---|
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continuous Versus 1-min Oscillometric Arterial BP Monitoring (NA)
- Impact of Remimazolam on Prognosis After Bladder Cancer Surgery (PHASE4)
- Effect of General and Non-general Anesthesia on Perioperative Depression or Anxiety (NA)
- Effect of Esketamine on Depressive Symptoms of Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (NA)
- Total Intravenous Anesthesia Versus Sevoflurane Anesthesia for Endovascular Thrombectomy in Acute Ischemic Stroke (NA)
- Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery (PHASE4)
- Anesthesia-analgesia Methods and Postoperative Delirium (NA)
- Hemodynamics and Vital Organ Function in Intracerebral Hemorrhage (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cisatracurium besylate,propofol,remifentanil,sevoflurane CI brief — competitive landscape report
- cisatracurium besylate,propofol,remifentanil,sevoflurane updates RSS · CI watch RSS
- First Affiliated Hospital Xi'an Jiaotong University portfolio CI
Frequently asked questions about cisatracurium besylate,propofol,remifentanil,sevoflurane
What is cisatracurium besylate,propofol,remifentanil,sevoflurane?
cisatracurium besylate,propofol,remifentanil,sevoflurane is a Small molecule drug developed by First Affiliated Hospital Xi'an Jiaotong University.
Who makes cisatracurium besylate,propofol,remifentanil,sevoflurane?
cisatracurium besylate,propofol,remifentanil,sevoflurane is developed and marketed by First Affiliated Hospital Xi'an Jiaotong University (see full First Affiliated Hospital Xi'an Jiaotong University pipeline at /company/first-affiliated-hospital-xi-an-jiaotong-university).
What development phase is cisatracurium besylate,propofol,remifentanil,sevoflurane in?
cisatracurium besylate,propofol,remifentanil,sevoflurane is FDA-approved (marketed).